Adverse effects of BCG vaccination. Mainly BCG infection

Prescrire International

Volumn 12, Issue 68, 2003, Pages 220-224

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCG PASTEUR; BCG VACCINE; CORTICOSTEROID; DEXTRAN; IMMUNOSUPPRESSIVE AGENT; PYRAZINAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANAPHYLACTIC SHOCK; ARTICLE; ATOPIC DERMATITIS; BACTERIAL INFECTION; BCG VACCINATION; CONJUNCTIVITIS; DATA ANALYSIS; DRUG INTOXICATION; EYE DISEASE; FISTULA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KELOID; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS; LYMPHADENITIS; MENINGITIS; OSTEITIS; POSTOPERATIVE INFECTION; RISK ASSESSMENT; RISK FACTOR; SKIN ABSCESS; SKIN NECROSIS; SKIN ULCER; TUBERCULOSIS;

BCG VACCINE; HUMANS; MASS IMMUNIZATION; RISK FACTORS; TUBERCULOSIS;

EID: 0344877299     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Institut de Veille Sanitaire "Impact épidémiologique d'une modification de la politique de vaccination par le BCG en France. Revue de la littérature et analyse des données disponibles" July 2001: 42 pages.
2. French datasheet compendium "Dictionnaire Vidal" Vidal, Paris 2003.
3. Holt DF et al. "Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination" Clin Infect Dis 1999; 28: 785-790.
4. Prescrire Rédaction "Petite histoire... du BCG - le hasard, l'observation et la pugnacité" Rev Prescrire 1995; 15 (154): 635-636.
5. "Le BCG dans les programmes de vaccination" Rel Epidémiol Hebd/Wkly Epidemiol Rec 2001; 76 (5): 33-39.
6. o96-775 du 5 septembre 1996 relatif à la vaccination par le vaccin antituberculeux BCG et modifiant le code de la santé publique (deuxième partie: décrets en Conseil d'État)" Journal Officiel 7 September 1996: 13376.
7. o pour scarification" Rev Prescrire 1990; 10 (98 ): 291.
8. "Arrêté du 5 septembre 1996 relatif à la pratique de la vaccination par le vaccin antituberculeux BCG et aux tests tuberculiniques" Journal Officiel 7 September 1996: 13385-13386.
9. Lotte A et al. "BCG complications" Adv Tuber Res 1984; 21: 107-245.
10. World Health organization "Surveillance of adverse events following immunization. Field guide for managers of immunization programmes" Geneva 1997: 48 pages.
11. Grange JM "Complications of bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management" Commun Dis Public Health 1998; 1 (2): 84-88.
12. Direction générale de la santé - Comité technique des vaccinations "Guide des vaccinations" CFES, Vanves 1999: 194 pages.
13. Vittori F and Groslafeige C "Le lupus tuberculeux post-BCG. Une complication rare de la vaccination" Arch Pédiatr 1996; 3: 457-459.
14. Dittmann S "Bacille Calmette-Guérin (BCG) vaccine". In: "Meyler's Side Effects of Drugs" 14th ed, Elsevier, Amsterdam 2000: 1056-1102.
15. Kröger L et al. "Osteitis caused by bacille Calmette-Guérin vaccination: a retrospective analysis of 222 cases" J Infect Dis 1995; 172: 574-576.
16. Hoppe JE et al. "Costal BCG osteomyelitis presenting as a tumor" Infection 1992; 20 (2): 94-96.
17. Karnak I "Granulomatous osteomyelitis of the sternum presenting with a parasternal mass: a possible relation to the bacillus Calmette-Guérin vaccine" J Pediatr Surg 1999; 34 (10): 1534-1536.
18. Lin CJ et al. "Mycobacterium bovis osteomyelitis as a complication of Bacille Calmette-Guérin (BCG) vaccination: rapid diagnosis with use of DNA sequencing analysis" J Bone Joint Surg 1999; 81-A (9): 1305-1311.
19. Talbot EA et al. "Disseminated bacille Calmette-Guérin disease after vaccination: case report and review" Clin Infect Dis 1997; 24: 1139-1146.
20. Yan JJ et al. "Differentiation of BCG-induced lymphadenitis from tuberculosis in lymph node biopsy specimens by molecular analyses of pncA and oxyR" J Pathol 1998; 184: 96-102.
21. Casanova JL "Prédisposition mendélienne aux infections mycobactériennes chez l'Homme" J Soc Biol 2000; 194 (1): 25-28.
22. Casanova JL et al. "Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study" Pediatrics 1996; 98 (4): 774-778.
23. Tardieu M et al. "Tuberculous meningitis due to BCG in two previously healthy children" Lancet 1988; i: 440-441.
24. Tshabalala RT "Anaphylactic reactions to BCG in Swaziland" Lancet 1983; ii: 653.
25. Pönnighaus JM et al. "Hypersensitivity to dextran in BCG vaccine" Lancet 1991; 337: 1039.
26. Fauquert JL et al "Réaction anaphylactoïde post-BCG: le rôle du Dextran?" Rev Fr Allergol Immunol Clin 2001; 41: 412-414.
27. Rudin C et al. "Anaphylactoid reaction to BCG vaccination" Lancet 1991; 337: 377.
28. Badeyan G and Guignon N "Vaccination contre la tuberculose: seuls deux tiers des enfants de six ans ont entièrement satisfait à l'obligation vaccinale" DREES Études et résultats 1999 (8): 4 pages.
29. o spécial): 1.
30. South African Tuberculosis Study Group "Comparison of several BCG vaccines and methods of administration" S Afr Med J 1973; 47: 2207-2218.
31. Mori T et al. "Lymph node swelling due to bacille Calmette-Guérin vaccination with multipuncture method" Tuber Lung Dis 1996; 77: 269-273.
32. FitzGerald JM "Management of adverse reactions to bacille Calmette-Guérin vaccine" Clin Infect Dis 2000; 31 (suppl. 3 ): 75-76.
33. Lotte A et al. "Second IUALTD study on complications induced by intradermal BCG-vaccination" Bull Int Union Tuber Lung Dis 1988; 63 (2): 47-59.
34. Miles MM and Shaw RJ "Effect of inadvertent intradermal administration of high dose percutaneous BCG vaccine" BMJ 1996; 312: 1205.
35. Puliyel JM et al. "Adverse local reactions from accidental BCG overdose in infants" BMJ 1996; 313: 528-529.
36. Behr MA "Correlation between BCG genomics and protective efficacy" Scand J Infect Dis 2001; 33: 249-252.
37. Centers for Disease Control and Prevention "The role of BCG vaccine in the prevention and control of tuberculosis in the United States" MMWR 1996; 45 (4): 19 pages.
38. Lugosi L "Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A review" Tuber Lung Dis 1992; 73: 252-261.
39. Wittes RC "Immunology of Bacille Calmette-Guérin and related topics" Clin Infect Dis 2000; 31 (suppl.3): 59-63.
40. Zhang Y et al. "Genetic differences between BCG substrains" Tuber Lung Dis 1995; 76: 43-50.
41. Teulieres L et al. "Comparative trial of administration of half (0.05 mg) and quarter (0.025 mg) dose of intradermal Pasteur BCG on 291 infants from birth to 1 year in French Guyana" Vaccine 1991; 9: 521-524.
42. Guérin N et al. "Comparison of the safety and immunogenicity of the lyophilized Mérieux seed and the World Health Organization working reference BCG vaccines in school-aged children in Senegal" Vaccine 1999; 17: 105-109.
43. Milstien JB and Gibson JJ "Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety" Bull WHO 1990; 68 (1): 93-108.
44. Hengster P et al. "Occurrence of suppurative lymphadenitis after a change of BCG vaccine" Arch Dis Child 1992; 67: 952-955.
45. Hengster P et al. "Surgical treatment of Bacillus Calmette Guérin lymphadenitis" World J Surg 1997; 21: 520-523.
46. Romanus V et al. "Adverse reactions in healthy and immunocompromised children under six years of age vaccinated with the Danish BCG vaccine, strain Copenhagen 1331: implications for the vaccination policy in Sweden" Acta Paediatr 1993; 82: 1043-1052.
47. "BCG vaccines". In: "British National Formulary" British Medical Association - Royal Pharmaceutical Society of Great Britain, London September 2002; (44): 586-589.
48. "BCG vaccines". In: "Martindale The Complete Drug Reference" 33rd ed, The Pharmaceutical Press, London 2002: 1533-1534.
49. Jeena PM et al. "Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban, South Africa" Bull World Health Organ 2001; 79 (4): 337-343.
50. Pollard AJ and George RH "Ocular contamination with BCG vaccine" Arch Dis Child 1994, 70: 71.
51. Pasteur MC and Hall DR "The effects of inadvertent intramuscular injection of BCG vaccine" Scand J Infect Dis 2001; 33: 473-474.
52. Ildirim I et al. "Comparison of BCG vaccination at birth and at third month of life" Arch Dis Child 1992; 67: 80-82.
53. Matsaniotis N "Dangers of immunization in immunologically incompetent individuals" Acta Paediatr Scand 1967; 172 (suppl.): 146-155.
54. Casanova JL and Abel L "Genetic dissection of immunity to mycobacteria: the human model" Annu Rev Immunol 2002; 20: 581-620.
55. Waddell RD et al. "Bacteremia due to Mycobacterium tuberculosis or M. bovis, bacille Calmette-Guérin (BCG) among HIV-positive children and adults in Zambia" AIDS 2001; 15: 55-60.
56. Prescrire Rédaction "Risques du BCG chez les enfants HIV positifs" Rev Prescrire 1995; 15 (148): 143.
57. Prescrire Editorial Staff "Vaccination of children born to HIV-infected mothers" Prescrire Int 1993; 2 (6): 93-94.
58. Prescrire Editorial Staff "Vaccination of HIV-infected patients" Prescrire Int 1993; 2 (11): 87-88.
59. Delfraissy JF et al. "Prise en charge des persones infectées par le VIH. Recommandations du groupe d'experts" Flammarion Médecine-Sciences, Paris 2002: 210-211.
60. "Art.L. 2122-1 Examens de prévention durant et après la grossesse" code de la santé publique. Website www.legifrance.gouv.fr consulted on 13 March 2003.
61. Turnbull FM et al. "National study of adverse reactions after vaccination with Bacille Calmette-Guérin" Clin Infect Dis 2002; 34: 447-453.
62. Banac S and Franulovic J "Familial liability to complications after BCG vaccination" Acta Paediatr 1997; 86: 899-902.
63. Casanova JL "Infection disséminée idiopathique par le BCG ou les mycobactéries atypiques" Arch Pédiatr